Remicade, Lyophilisat - Durchstechflasche(n) Swissmedic Key 55184001 Registration Holder Janssen-Cilag AG Name Remicade, Lyophilisat Date of registration 21.12.1999 Introduction of Sequence 21.12.1999 ATC-Classification Infliximab (L04AB02) Revision date 25.07.2007 WHO WHO-DDD Valid until Index Therapeuticus (BSV) 07.15. Show package size Durchstechflasche(n) Index Therapeuticus (Swissmedic) 07.15. Description Swissmedic categorie. A SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 506.30 Limitation Yes Limitation text
Deductible 10 % Consumer price 565.50 Feedback FB Daily cost GTIN 7680551840015 Medication Code Biotechnologika Pharmacode 2191180 Disponibility
Composition Praeparatio cryodesiccata: infliximabum 100 mg, natrii dihydrogenophosphas monohydricus, dinatrii phosphas dihydricus, saccharum, polysorbatum 80, pro vitro corresp. natrium 1.943 mg. Packungsbestandteile Label Praeparatio cryodesiccata:
Galenic Form Lyophilisate Excipiens Active Agent Dose Infliximab 100 mg
BAG: Active Agent Dose Infliximab 100 mg
Inactive agents Disodium Phosphate Dihydrate Sodium Dihydrogenophosphate Monohydrate Polysorbatum 80 Saccharum
Source Data was imported : 06.11.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
